Darryl Outlaw is an Oncology physician affiliated with University of Alabama at Birmingham. OpenAlex indexes 67 publications with 3,865 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
625 19th St S
Birmingham, AL 352331900
Telephone
205-934-2490Provider last certified this registry record 19 Apr 2022.
Industry payments
10 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Merck Sharp & Dohme LLCProgram year20253 payments
- E.R. Squibb & Sons, L.L.C.Program year20253 payments
- Caris MPI, Inc.Program year20252 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Nervous system
32.3%Opioid Agonist11.9%Oxycodone Hcl78%Morphine Sulfate Er22%Part D<11 patientsAtypical Antipsychotic10.5%Olanzapine100%Part D≥33 patients+ 4 more classes in this area
Metabolism & gastrointestinal
29.6%Serotonin-3 Receptor Antagonist16.2%Ondansetron Hcl74%Ondansetron Odt26%Part D≥52 patientsAntidiarrheal microorganisms3.7%Creon100%Part D<11 patients+ 4 more classes in this area
Blood & clotting
12.6%Factor Xa inhibitor10.8%Eliquis100%Part D≥20 patientsSalt solutions1.8%Sodium Chloride100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- BPI25-016: Real-World Outcomes of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer: Insights From a Single Center in the Deep South
Journal of the National Comprehensive Cancer Network
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Vera Bittner
University of Alabama at Birmingham
Richard Whitley, MD
University of Alabama at Birmingham
David Standaert, MD, PhD
University of Alabama at Birmingham
Erik Roberson
University of Alabama at Birmingham
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”